Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Report summarizes breast cancer study findings from University Hospital
July 24th, 2008
" In the treatment of extensive liver metastasis of breast cancer (LMBC), locally administered Mitomycin C (MMC) to the liver might be an effective approach with limited toxicity. Patients and methods We retrospectively reviewed the records of 30 patients with LMBC treated with intra-hepatic MMC at our institution," researchers in Louvain, Belgium report. "MMC (12 mg) was administered by transcatheter bolus infusion into the hepatic arteries every 4 weeks. Tumour response according to RECIST criteria, progression free survival (PFS), overall survival (OS) and duration of response (DR) were used to evaluate efficacy. There was a local response in the liver and a global...
Source: Women's Health Weekly (2008-07-24)
|
